• Onto Innovation (NYSE:ONTO) announced a collaboration with Rigaku Holdings Corporation focused on next generation semiconductor process control solutions.
• As part of the agreement, Onto is investing $710 million for a 27% equity stake in Rigaku and gains the right to nominate a director.
• The partnership combines Onto's AI enabled metrology software with Rigaku's X ray technologies to target hybrid metrology for advanced logic and memory manufacturing.

For investors tracking NYSE:ONTO, this move sits at the core of the company's role in semiconductor process control, where tighter tolerances and growing chip complexity are driving demand for more precise inspection and metrology. By tying its software to Rigaku's X ray hardware, Onto is positioning itself more directly in hybrid metrology, an area targeting a market that is expected to exceed $1b.

The equity stake, joint IP focus and board representation indicate that Onto is treating Rigaku as a long term partner rather than a simple technology supplier. For investors, the key issues to monitor will be the pace at which the two companies can commercialize combined offerings and whether this relationship creates meaningful incremental revenue opportunities over time.

Stay updated on the most important news stories for Onto Innovation by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Onto Innovation.

This Rigaku deal pushes Onto Innovation deeper into X-ray based process control rather than staying purely on the optical and software side. By tying its Ai Diffract analysis software directly to Rigaku’s CD-SAXS X-ray platforms, Onto is effectively trying to own a larger slice of hybrid metrology for leading edge logic and memory, where companies such as KLA, Applied Materials and ASML also compete for process control budgets. The roughly US$710 million outlay for a 27% stake is sizeable, so the success of this collaboration will matter for how efficiently Onto converts capital into new product traction and customer share in a market that external analysts see moving toward US$1b.

How This Fits Into The Onto Innovation Narrative

• The hybrid metrology focus directly supports the narrative that Onto can broaden its process control toolkit as chipmakers move to advanced packaging and 2.5D or 3D architectures.
• The size of the Rigaku investment adds another execution checkpoint on top of integration work such as Semilab, which the narrative already highlights as a key task.
• The specific push into X-ray based CD-SAXS and hybrid metrology is not fully reflected in the existing community narrative, which leans more on optical metrology, Dragonfly and electrical metrology from acquisitions.

Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Onto Innovation to help decide what it's worth to you.

The Risks and Rewards Investors Should Consider

• ⚠️ Large capital commitment of about US$710 million for a minority stake, with no consolidation of Rigaku’s financials, means investors need the fair value of that stake and the commercial outputs to justify the spend.
• ⚠️ Execution risk around integrating software, aligning product roadmaps and coordinating sales with a separate company, on top of other projects like Semilab, could stretch management focus.
• 🎁 The collaboration aims to address a process control market that external analysts estimate could exceed US$1b, giving Onto more ways to sell Ai Diffract and optical critical dimension solutions into advanced logic and memory customers.
• 🎁 Early selection of the combined X-ray solution by two key customers suggests some initial product market fit, which could support Onto’s goal of deeper share in complex nodes if adoption broadens.

What To Watch Going Forward

From here, the main things for you to track are how quickly Onto and Rigaku convert the joint X-ray and Ai Diffract platform into broader customer wins, whether the partnership supports Onto’s guidance on revenue and margins, and how the company balances this new tie up with its work on Dragonfly G5 and Semilab. Closing conditions, regulatory approvals and any updates on the expected accretive timing by the end of 2026 are also worth watching, as they will show how the financial side of the deal is tracking versus expectations.

To ensure you're always in the loop on how the latest news impacts the investment narrative for Onto Innovation, head to the community page for Onto Innovation to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.